| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.76 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |